BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 28 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $40 | -99.9% | 44,000 | -7.4% | 0.06% | -6.0% |
| Q3 2022 | $52,000 | -38.8% | 47,500 | -31.2% | 0.07% | -33.7% |
| Q2 2022 | $85,000 | -56.9% | 69,000 | -17.4% | 0.10% | -67.5% |
| Q1 2022 | $197,000 | -38.2% | 83,584 | -18.7% | 0.31% | -24.3% |
| Q4 2021 | $319,000 | -8.1% | 102,781 | +20.2% | 0.41% | -12.2% |
| Q3 2021 | $347,000 | -21.1% | 85,500 | -6.0% | 0.47% | -22.6% |
| Q2 2021 | $440,000 | +38.8% | 90,920 | +48.9% | 0.60% | +69.0% |
| Q1 2021 | $317,000 | -47.7% | 61,042 | -32.8% | 0.36% | -65.0% |
| Q4 2020 | $606,000 | -49.2% | 90,884 | -22.4% | 1.02% | -60.5% |
| Q3 2020 | $1,193,000 | -24.0% | 117,144 | -6.3% | 2.59% | -39.2% |
| Q2 2020 | $1,569,000 | +186.3% | 125,000 | +150.0% | 4.26% | +122.6% |
| Q1 2020 | $548,000 | – | 50,000 | – | 1.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 44,000 | $40 | 0.06% |
| NTV ASSET MANAGEMENT LLC | 12,605 | $11,345 | 0.00% |
| Sepio Capital, LP | 23,800 | $21,420 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 500 | $450 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,000 | $1,000 | 0.00% |
| US BANCORP \DE\ | 1,221 | $1,099 | 0.00% |
| WELLS FARGO & COMPANY/MN | 191,065 | $171,959 | 0.00% |
| NORTHERN TRUST CORP | 28,097 | $25,287 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,196 | $57 | 0.00% |